DRREDDY.BO

Dr. Reddy's Laboratories Limited · Healthcare · Drug Manufacturers - Specialty & Generic

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$11.59B

PE Ratio

19.67

EV to Ebitda

—

Earnings Yield

5.00%

Revenue (TTM)

$3.60B

Net Income (TTM)

$589.1M

Revenue (Annual YoY Growth)

—

Revenue (Quarterly YoY Growth)

4.00%

Profit Margin

16.00%

Return on Equity

—

Debt to Equity Ratio

—

Dividend Yield

1.00%

All fundamentals

Core6 fields›

Market Cap$11.59B

Revenue TTM$3.60B

Shares Outstanding832.6M

Float121918695

Insider Ownership29.00%

Institutional Ownership52.00%

Growth Estimates7 fields›

Revenue Growth (Quarterly YoY)4.00%

Rev Growth Est 1Y Forward0.04

EPS Growth (Quarterly YoY)-14.00%

EPS Growth Est Quarterly14.41

LT EPS Growth Estimates-11.00%

CFO Growth (Quarterly YoY)65.00%

FCF Growth (Quarterly YoY)-263.00%

Operations21 fields›

Revenue TTM$3.60B

Gross Margin TTM55.00%

Gross Margin (Quarterly)65.00%

Operating Margin TTM16.00%

Operating Margin (Quarterly)16.00%

Operating Expenses TTM$34.7M

Profit Margin TTM16.00%

Profit Margin (Quarterly)14.00%

Net Income TTM$589.1M

EPS TTM67.84

EPS (Quarterly)14.53

EBIT Margin TTM23.86%

EBITDA Margin TTM25.00%

EBITDA TTM$882.6M

CFO % of Revenue TTM30.00%

CFO % of Revenue (Quarterly)12.00%

CFO TTM$1.06B

Capex % of Revenue TTM21.00%

Capital Expenditures$751.1M

FCF % of Revenue (Quarterly)3.00%

FCF TTM$252.5M

Efficiency1 fields›

ROA8.00%

Valuation12 fields›

P/E (TTM)19.67

P/E Forward25.32

PEG3.83

P/CFO10.89

P/FCF45.89

EV/Revenues (TTM)3.11

Price To Book2.99

Price to Tangible Book4.32

Earnings Yield5.00%

FCF Yield2.00%

Dividend Yield1.00%

Payout Ratio16.00%

Liquidity8 fields›

Cash Per Share69.42

Current Ratio1.92

Goodwill & Intangibles$114727.00T

Total Assets$5.86B

Total Liabilities$7.17B

Shareholders Equity$3.88B

Interest Expense$34.7M

Goodwill % of Assets20381454.00%

Yields4 fields›

Dividend Yield1.00%

Payout Ratio16.00%

Earnings Yield5.00%

Buyback Yield0.00%